Overview on Post-Inflammatory Hyperpigmentation
Abdulrahman M. Albahlool *
King Fahad General Hospital - Jeddah, Jeddah, Saudi Arabia.
Omar Khalid M. Alshehri
Ministry of Health, Saudi Arabia.
Saeed Mohammed Alrasheed
Ministry of Health, Saudi Arabia.
Muzaynah Abdullah Al Ali
Security Forces Health Center in Jazan, Saudi Arabia.
Abdullah Owaidh R. Al Sharif
Taif University, Saudi Arabia.
*Author to whom correspondence should be addressed.
Abstract
Post inflammatory hyperpigmentation (PIH) can affect people of all skin colours, but it is more common in people of colour, such as African Americans, Hispanics/Latinos, Asians, Native Americans, Pacific Islanders, and those of Middle Eastern descent. There is no distinction between men and women. In darker-skinned acne sufferers, the prevalence of PIH might reach 65 percent. Many studies have demonstrated that topical retinoids, especially in darker skin types, can be beneficial in treating PIH associated with acne. However, Hydroquinone is still a go-to treatment for melasma and hyperpigmentation, and it's commonly referred to as the "gold standard." triple combination fixed treatment has also become a common intervention, with evidence showing that the combination is more successful than hydroquinone monotherapy. In this review article we will be looking at PIH etiology, epidemiology, different treatment options as well as the effectiveness of each medication.
Keywords: Retinoid, hyperpigmentation, PIH, hypermelanosis